Jenny E Kanter

12PUBLICATIONS
58CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Haematological tumoursMedical biochemistry - lipidsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 22, 2026
SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes.

|Jun 04, 2026
Kidney-Vascular Metabolic Crosstalk: Altered Lipoproteins in CKD.

|Jan 03, 2026
Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice.

Ainara G Cabodevilla, Maria Concepcion Izquierdo, Debapriya Basu

|Jun 03, 2024
Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.

Vishal Kothari, Tse W W Ho, Ainara G Cabodevilla

|May 25, 2023
Quartet of APOCs and the Different Roles They Play in Diabetes.

Cheng-Chieh Hsu, Jenny E Kanter, Vishal Kothari

|Apr 21, 2023
Hematopoietic NLRP3 and AIM2 Inflammasomes Promote Diabetes-Accelerated Atherosclerosis, but Increased Necrosis Is Independent of Pyroptosis.

Cheng-Chieh Hsu, Trevor P Fidler, Jenny E Kanter

Pageof 2

Frequent Collaborators

8 joint publications

Karin E Bornfeldt

3 joint publications

Tomas Vaisar

3 joint publications

Vishal Kothari

2 joint publications

Ira J Goldberg